| 1 |
Young NS. Aplastic anemia[J]. N Engl J Med, 2018, 379(17):1643-1656.
|
| 2 |
杨洁茹, 王化泉, 邵宗鸿. 再生障碍性贫血发病机制的研究进展[J]. 中华血液学杂志, 2019, 40(9):796-800.
|
| 3 |
Bacigalupo A. How I treat acquired aplastic anemia[J]. Blood, 2017, 129(11):1428-1436.
|
| 4 |
Young NS, Kaufman DW. The epidemiology of acquired aplastic anemia[J]. Haematologica, 2008, 93(4):489-492.
|
| 5 |
Georges GE, Doney K, Storb R. Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment[J]. Blood Adv, 2018, 2(15):2020-2028.
|
| 6 |
Dufour C, Pillon M, Sociè G, et al. Outcome of aplastic anaemia in children: a study by the Severe Aplastic Anaemia and Paediatric Disease Working Parties of the European Group for Blood and Bone Marrow Transplantation[J]. Br J Haematol, 2015, 169(4):565-573.
|
| 7 |
Yoshida N, Kobayashi R, Yabe H, et al. First-line treatment for severe aplastic anemia in children: bone marrow trans-plantation from a matched family donor versus immunosuppressive therapy[J]. Hae-matologica, 2014, 99(12):1784-1791.
|
| 8 |
Dufour C, Pillon M, Passweg J, et al. Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation[J]. Haematologica, 2014, 99(10):1574-1581.
|
| 9 |
Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders[J]. Expert Rev Hematol, 2010, 3(1): 103-117.
|
| 10 |
Origa R. β-Thalassemia[J]. Genet Med, 2017, 19(6):609-619.
|
| 11 |
Taher A, Weatherall D, Cappellini M. Thalassaemia[J]. Lancet, 2018, 391(10116): 155-167.
|
| 12 |
中华医学会医学遗传学分会遗传病临床实践指南撰写组. β-地中海贫血的临床实践指南[J]. 中华医学遗传学杂志, 2020, 37(3):243-251.
|
| 13 |
中华医学会血液学分会干细胞应用学组. 中国异基因造血干细胞移植治疗血液系统疾病专家共识（Ⅰ）——适应证、预处理方案及供者选择（2014年版）. 中华血液学杂志, 2014, 35(8):775-780.
|
| 14 |
Worel N, Buser A, Greinix HT, et al. Suitability criteria for adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues[J]. Biol Blood Marrow Transplant, 2015, 21(12):2052-2060.
|
| 15 |
Moura IC, Hermine O. Erythroferrone: the missing link in β-thalassemia?[J]. Blood, 2015, 126(17):1974-1975.
|
| 16 |
Asadov C, Alimirzoeva Z, Mammadova T, et al. β-Thalassemia intermedia: a comprehensive overview and novel approaches[J]. Int J Hematol, 2018, 108(1):5-21.
|
| 17 |
Jung MY, Lim YT, Lim H, et al. Successful hematopoietic stem cell transplantation from a matched related donor with beta-thalassemia minor for severe aplastic anemia[J]. Children (Basel), 2020, 7(10):162.
|
| 18 |
Olsson R, Remberger M, Schaffer M, et al. Graft failure in the modern era of allogeneic hematopoietic SCT[J]. Bone Marrow Transplant, 2013, 48(4):537-543.
|
| 19 |
Iftikhar R, Chaudhry QUN, Satti TM, et al. Comparison of conventional cyclophosphamide versus fludarabine-based conditioning in high-risk aplastic anemia patients undergoing matched-related donor transplantation[J]. Clin Hematol Int, 2020, 2(2):82-91.
|